Vanderbilt Memory and Alzheimer’s Center

Brina Ratangee talks about her poster during Alzheimer's Disease Research Day. (photo by Susan Urmy)

Event highlights Alzheimer’s disease research

The 5th Annual Vanderbilt Alzheimer’s Disease Research Day, sponsored by the Vanderbilt Memory and Alzheimer’s Center (VMAC), was held April 10 at Vanderbilt University School of Nursing.

Images predict functional decline

MRI brain scans at baseline for study participants 60 and older — who were free of clinical dementia at study entry — predicted a decline in independent function five years later.

How arterial “stiffness” may impair cognition

New findings from Vanderbilt neurologists suggest that cardiovascular disease may increase the spaces surrounding blood vessels in the brain and lead to cognitive decline.

Alzheimer’s risk factor and cognition

Vanderbilt researchers found that a protein with roles in innate immunity worsens memory at baseline in carriers of APOE-e4, the strongest genetic risk factor for Alzheimer’s disease, further implicating neuroinflammation in cognitive decline.

Minority patients less likely to have amyloid plaques necessary for Alzheimer’s treatments

Fewer Black, Hispanic and Asian patients meet biomarker qualifications for landmark treatments that may slow the progression of Alzheimer’s disease by targeting amyloid plaques, according to new findings published in JAMA Neurology.

Today Show: Vanderbilt Memory and Alzheimer’s Center makes national push for clinical study enrollment. You can help.

The Today Show’s Maria Shriver spotlighted a landmark, years-long study into the connection between heart health and Alzheimer’s disease, and the urgency to boost study enrollment—particularly among people of color who are disproportionally impacted yet historically underrepresented in research.

1 2 3